Regeneron Pharmaceuticals
REGN
#324
Rank
S$94.88 B
Marketcap
S$905.06
Share price
-0.97%
Change (1 day)
22.53%
Change (1 year)

Earnings for Regeneron Pharmaceuticals (REGN)

Earnings in 2026 (TTM): S$6.61 Billion

According to Regeneron Pharmaceuticals's latest financial reports the company's current earnings are S$14.91 Billion. In 2025 the company made an earning of S$6.64 Billion, an increase over its 2024 earnings that were of S$6.06 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regeneron Pharmaceuticals from 1990 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) S$6.61 B-0.43%
2025 S$6.64 B9.43%
2024 S$6.06 B13.83%
2023 S$5.33 B-13.57%
2022 S$6.16 B-47.9%
2021 S$11.84 B144.75%
2020 S$4.83 B56.86%
2019 S$3.08 B-4.87%
2018 S$3.24 B22.86%
2017 S$2.63 B56.3%
2016 S$1.68 B8.55%
2015 S$1.55 B54.53%
2014 S$1.00 B11.14%
2013 S$0.90 B72.13%
2012 S$0.52 B-285.93%
2011 -S$0.29 Billion121.73%
2010 -S$0.13 Billion37.18%
2009 -S$93.04 Million-14.6%
2008 -S$0.11 Billion-25.02%
2007 -S$0.15 Billion6.32%
2006 -S$0.14 Billion-186.52%
2005 S$0.15 B2103.7%
2004 S$7.16 M-105.66%
2003 -S$0.13 Billion-18.18%
2002 -S$0.16 Billion42.33%
2001 -S$0.11 Billion129.35%
2000 -S$47.44 Million51.87%
1999 -S$31.24 Million92.19%
1998 -S$16.26 Million66.23%
1997 -S$9.78 Million-55.49%
1996 -S$21.97 Million103.53%
1995 -S$10.8 Million-70.89%
1994 -S$37.08 Million-26.08%
1993 -S$50.15 Million114.67%
1992 -S$23.37 Million196.77%
1991 -S$7.88 Million87.88%
1990 -S$4.19 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$32.98 B 403.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$20.03 B 206.08%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
S$11.53 B 76.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$9.72 B 48.51%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
S$2.06 B-68.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
S$1.10 B-83.14%๐Ÿ‡บ๐Ÿ‡ธ USA